241 related articles for article (PubMed ID: 11454998)
21. Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment.
Lohani K; Shetty S; Sharma P; Govindarajan V; Thomas P; Loggie B
Ann Surg Oncol; 2014 May; 21(5):1441-7. PubMed ID: 24046117
[TBL] [Abstract][Full Text] [Related]
22. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
[TBL] [Abstract][Full Text] [Related]
23. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
Mohamed F; Gething S; Haiba M; Brun EA; Sugarbaker PH
J Surg Oncol; 2004 Apr; 86(1):10-5. PubMed ID: 15048674
[TBL] [Abstract][Full Text] [Related]
24. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Nonaka D; Cabras AD; Laterza B; Deraco M
Ann Surg; 2009 Feb; 249(2):243-9. PubMed ID: 19212177
[TBL] [Abstract][Full Text] [Related]
25. Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.
Semino-Mora C; Liu H; McAvoy T; Nieroda C; Studeman K; Sardi A; Dubois A
Ann Surg Oncol; 2008 May; 15(5):1414-23. PubMed ID: 18299935
[TBL] [Abstract][Full Text] [Related]
26. Pseudomyxoma peritonei: a cytohistopathologic study of nine cases.
Mulvany N; Ooi K
Diagn Cytopathol; 1996 Aug; 15(2):144-50. PubMed ID: 8872439
[TBL] [Abstract][Full Text] [Related]
27. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei.
Bibi R; Pranesh N; Saunders MP; Wilson MS; O'dwyer ST; Stern PL; Renehan AG
Br J Cancer; 2006 Nov; 95(9):1258-64. PubMed ID: 17031402
[TBL] [Abstract][Full Text] [Related]
28. Pseudomyxoma peritonei--a heterogenous disease.
Shen DH; Ng TY; Khoo US; Xue WC; Cheung AN
Int J Gynaecol Obstet; 1998 Aug; 62(2):173-82. PubMed ID: 9749889
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution.
Semino-Mora C; Testerman TL; Liu H; Whitmire JM; Studeman K; Jia Y; McAvoy TJ; Francis J; Nieroda C; Sardi A; Merrell DS; Dubois A
Clin Cancer Res; 2013 Jul; 19(14):3966-76. PubMed ID: 23743566
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary metastases in pseudomyxoma peritonei syndrome.
Mortman KD; Sugarbaker PA; Shmookler BM; DeGuzman VC; Soberman MS
Ann Thorac Surg; 1997 Nov; 64(5):1434-6. PubMed ID: 9386716
[TBL] [Abstract][Full Text] [Related]
31. Mucinous Balls Tangled With Mesothelial Cells and MUC2-Positive Cancer Cells in the Ascites of Pseudomyxoma Peritonei.
Akashi S; Kuwabara H; Yasuda E; Akutagawa H; Takeshita A; Kurisu Y; Egashira Y; Hirose Y; Yuki M; Tsuda Y; Hayashi M
Diagn Cytopathol; 2016 Jul; 44(7):628-31. PubMed ID: 27079739
[TBL] [Abstract][Full Text] [Related]
32. Epithelial cells and other cytologic features of pseudomyxoma peritonei in patients with ovarian and/or appendiceal mucinous neoplasms: a study of 12 patients including 5 men.
Shin HJ; Sneige N
Cancer; 2000 Feb; 90(1):17-23. PubMed ID: 10692212
[TBL] [Abstract][Full Text] [Related]
33. [An analysis of pathologic features and prognostic factors of 10 cases with pseudomyxoma peritonei].
Zhou X; Du X
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):543-6. PubMed ID: 8556915
[TBL] [Abstract][Full Text] [Related]
34. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
[TBL] [Abstract][Full Text] [Related]
35. [Pseudomyxoma peritonei--a case report].
Iarŭmov N; Terziev I; Toshev S; Angelov K; Velev G; Todorov G; Koĭchev A; Ilinov V
Khirurgiia (Sofiia); 2006; (3):15-9. PubMed ID: 18788112
[TBL] [Abstract][Full Text] [Related]
36. Low-grade appendiceal mucinous neoplasm with disseminated peritoneal adenomucinosis involving the uterus, mimicking primary mucinous endometrial adenocarcinoma: a case report.
Tanaka H; Kobayashi T; Yoshida K; Asakura T; Taniguchi H; Mikami Y
J Obstet Gynaecol Res; 2011 Nov; 37(11):1726-30. PubMed ID: 21733040
[TBL] [Abstract][Full Text] [Related]
37. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors.
Ferreira CR; Carvalho JP; Soares FA; Siqueira SA; Carvalho FM
Int J Gynecol Cancer; 2008; 18(1):59-65. PubMed ID: 17511804
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum].
Zhang H; Sun Y; Huang X; Jia L; Bai Y; Cao D
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):163-8. PubMed ID: 24842014
[TBL] [Abstract][Full Text] [Related]
39. Pseudomyxoma peritonei: a clinicopathologic analysis and follow-up of 21 patients.
Varona JF; Guerra JM; Salamanca J; Colina F; Lopez G; Morales M
Hepatogastroenterology; 2005; 52(63):812-6. PubMed ID: 15966210
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei.
Kelly KJ; Baumgartner JM; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1722-5. PubMed ID: 25395145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
